Nanomedicine in Treatment of Diseases

Inbunden, Engelska, 2024

Av Bushra Akhtar, Faqir Muhammad, Ali Sharif

1 799 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Nanomedicine biotechnology is applied to and used to study drug development, working mechanisms, diagnosis, and therapies. This textbook particularly written for biomedical applications of nanomedicine covers the whole range of disease treatments related to nanomedicine. This book serves the purpose of highlighting the current advancements of nanomedicines-based regimens which may be employed in disease treatment while it also contains the fundamental knowledge for biomedical researchers from all levels. Each chapter starts with an introduction/theory into the specified approaches for various disease states followed by detailed discussions for a comprehensive understanding. This book best suits advanced level students, but also provides an excellent updated material for researchers and healthcare workers related to nanomedicine and diseases treatment.

Produktinformation

Utgivningsdatum2024-01-28
Mått168 x 240 x 28 mm
Vikt871 g
FormatInbunden
SpråkEngelska
SerieLearning Materials in Biosciences
Antal sidor389
FörlagSpringer Verlag, Singapore
ISBN9789819976256

Tillhör följande kategorier

Apotek och farmaceuter inom Medicin
Sjukdomar och rubbningar inom Medicin
Biomedicinsk teknik inom Medicin
Andra medicinska specialiteter inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Teknik: allmänt inom Naturvetenskap och teknik
Farmakologi inom Medicin

Dr. Bushra Akhtar has earned her Doctor of Philosophy (Pharmacology) degree from University of Agriculture, Faisalabad, Pakistan. She studied Master of Philosophy (Pharmacology and Toxicology) from University of Veterinary and Animal Sciences, Lahore, Pakistan. She did Pharm-D from Bahauddin Zakariya University, Multan, Pakistan. She is working as lecturer in Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan. She has published 60 peer reviewed articles with impact factor around 160. She has one national patent to her credit. Dr. Bushra Akhtar has produced around 20 postgraduate students as major supervisor. She is the editorial board member of 02 impact factor journals. Dr. Faqir Muhammad has earned his Doctor of Philosophy degree in 2004 from North Carolina State University U.S.A and M.Sc. (Hons.) and DVM degrees from University of Agriculture Faisalabad. Dr. Faqir Muhammad is working as Professor and Chairman, Department of Biosciences,Faculty of Veterinary Sciences, Bahauddin Zakariya University Multan. He has the experience of working as Research Assistant Professor at Kansas State University, USA for two years. He is a full member of the Society of Toxicology. He has been awarded with Star Award 2005, the millennium life time award 2008, research productivity award 2012. He has contributed a number of book chapters in international books. He has published more than 150 peer reviewed articles with an impact factor of 255 and more than 3500 citations to his credit. Dr. Faqir Muhammad has won various Research Projects from National Funding Agencies worth of more than Rs 14 million.Dr. Ali Sharif is currently serving as an Assistant Professor and Incharge at Department of Pharmacology, Institute of Pharmacy, Lahore College for Women University, Lahore. He received his PhD in Pharmacology and Toxicology in 2016, University of Veterinary and Animal Sciences Lahore. He studied Master of Philosophy (Pharmaceutics) and B-Pharm from Bahauddin Zakariya University, Multan, Pakistan. He has a teaching experience of more than 13 years. He has produced more than 25 M.Phil. & Ph.D students as major supervisor. He is author of more than 65 research papers and book chapters with a cumulative impact factor of 150. He is the editorial board member of 03 impact factor journals.

SECTION-I. INTRODUCTION TO NANOMEDICINE.- Chapter-I. Nanomedicine: Present perspectives and future challenges.- Chapter-II. Advantages of Nanomedicine over Conventional Therapeutics.- SECTION-II. NANOMEDICINE IN TREATMENT OF DISEASES.- Chapter-III. Nanomedicines for the treatment of bacterial diseases.- Chapter-IV. Nanomedicine in the treatment of viral diseases.- Chapter-V. Nanomedicines in the treatment of nervous system disorders.- Chapter-VI. Nanomedicines in treatment of cancer.- Chapter-VII. Nanomedicine in the treatment of Metabolic diseases.- Chapter-VIII. Nanomedicines in the Treatment of Fungal Diseases.- Chapter-IX. Nanomedicines in the treatment of skin diseases.- Chapter-X. Nanomedicines in the treatment of gastrointestinal disorders.- Chapter-XI. Nanomedicines in Treatment of Cardiovascular Diseases.- SECTION-III. CURRENT STATUS OF NANOMEDICINE IN CLINICAL APPLICATIONS.- Chapter-XII. Current status of nanomedicines in clinical practice.